Ọgwụ na-adabere na liraglutide maka oke ibu

Ogwu ahu di n’okpuru aha ahia Viktoza na Saksenda. Ọ bụ ụzọ doro anya, enweghị agba maka nchịkwa subcutaneous. A na-ere mmiri ahụ n'ime katrized iko, nke a na-etinye ya na sirinji plates ọtụtụ nwere ọtụtụ maka irigha ugboro ma tinye ya na kaadiboodu.

Saxenda na Viktoza nwere otu olu. Ihe eji arụ ọrụ bụ liraglutide, ihe ndị ọzọ bụ sodium hydrogen phosphate dihydrate, hydrochloric acid / sodium hydroxide, phenol, mmiri maka injection, propylene glycol.

Omume ọgwụ

Ihe dị n’ọgwụ ike bụ nnomi mmadụ nke glucose dị ka peptide-1. GLP-1 nke mepụtara na-apụtachaghị ihe dị na mbụ (ogo nke myirịta bụ 97%), yabụ ahụ anaghị ahụ ihe dị iche n'etiti ha. Site na nchịkwa subcutaneous, liraglutide na-ejikọ ndị na-anabata ya, na-eme ka mmepụta glucagon na insulin na-arụ ọrụ. Ka oge na-aga, insulin na-amalite imepụta n'onwe ya, nke na-eduga n'ịhazi ịdị elu nke ọ̀tụ̀tụ̀ shuga dị n'ọbara.

Usoro nke ihe nwere ike ịkọwapụta bụ ndị a:

Ọnụ ọgụgụ nke peptides na-abawanye.
Ọrụ nke pancreas na-akawanye mma, ọkwa shuga dị n'ọbara na-agbadata nkịtị.
A na-etinye nri ndị na-abanye n'ahụ mmadụ site na nri.
Ihe mgbaàmà nke izu ike batara na ụbụrụ.
Agụụ na-ebelata, ịbelata ibu na-apụta.

Ihe ngosi maka ojiji

Edere ọgwụ maka ndị okenye okenye nwere ọrịa shuga nke afọ 2 iji weghachite glycemic index ma belata ibu. Enwere ike iji ha dị ka ndị nnọchiteanya nọọrọ onwe ha yana dịka akụkụ nke ọgwụgwọ njikọta (ya na metformin, insulin, thiazolidinediones, sitere na ụdị sulfonylurea).

Ọ bụrụ na onye ọrịa na-arịa ọrịa shuga nwere ọrịa obi, a na-eji liraglutide dị ka akụkụ nke ọgwụgwọ siri ike iji belata ihe ọnya ọnya afọ, infarction myocardial, na ọnwụ.

Ntuziaka maka iji ọgwụ ahụ

Iji mesoo oke ibu, a na - eji Saksenda - ihe ngwọta maka nchịkwa subcutaneous. A na-ere ọgwụ ahụ n’ụdị sirinji mkpịsị ọlụlụ nwere ọnụ ahịa iji chọpụta usoro achọrọ. Inwere ike inye inje n'ụtụtụ, n'ehihie ma ọ bụ n'uhuruchi, n'agbanyeghị nri ahụ. Ndị dọkịta na-atụ aro inye ọgwụ ahụ n'otu oge n'ụbọchị iji hụ na oge nha dị n'etiti inje.

Iwu nke ọgwụ a dị ka ndị a:

Is na-etinye agịga n'okpuru anụ ahụ na nkwenye ndị nọọsụ ma ọ bụ dọkịta nyere. A na-ejide sirinji ahụ ka mgbochi ahụ wee dị n'anya.
Igodo mbido mmalite na-agbanye ma jidekwa ruo mgbe ọnụọgụ 0 gosipụtara n'ihu njiri dose.
Jide agịga n'okpuru anụ ahụ wee jiri nwayọọ gụọ 6.
Wepu agịga. Mgbe ọbara putara, a na-agbanye swab owu na-enweghị atụ n’ebe a na-agba ya.

Ekwesịrị ịhazi ihe ngwọta 1 oge kwa ụbọchị n'ubu, apata ụkwụ ma ọ bụ afọ. Ọgwụ kwa ụbọchị na-adabere na oge iji ọgwụ ahụ:

Izu 1 - 0.6 mg
Izu abụọ - 1.2 mg,
Izu atọ - 1.8 mg,
Izu anọ - 2.4 mg,
Izu ise na ụdi - 3 mg.

Amachibidoro ịhe karịrị 3 mg ọgwụ a kwa ụbọchị amachibidoro, n'ihi na nke a nwere ike ibute mmepe nke ịdoụbiga mmanya ókè.

O lee otu esi liraglutide maka ifelata?

Inje nke liraglutide na-ebelata usoro mgbaze, nke a na-eduga n’inwe agụụ na ịbelata nri caloric kwa ụbọchị site na 15-20%. Nke a na - akọwa oke arụmọrụ nke ihe ahụ na ọnụọgụ nyocha dị mma banyere ya.

Maka ịdị felata dị ezigbo mkpa, naanị inje inje ezughị. Ndị ọkachamara n'ihe banyere nri na-atụ aro iji injers yana usoro na ụzọ ndị ọzọ nke ifelata. Ihe ndị a tụrụ aro ga - enyere aka ime ka usoro a dị ngwa ngwa:

Ihe oriri kwesịrị ekwesị. Iji belata ibu, ọ dị mkpa belata ihe oriri kalori kwa ụbọchị. Iji mee nke a, hapụ ntụ ọka na ngwaahịa nri, nri abụba na eghe. Istsfọdụ ndị ọkachamara n'ihe banyere nri na-atụ aro iri obere nri ugboro 5 ruo 6 kwa ụbọchị, mana endocrinologists na-ekwu na ụdị nri ahụ nwere ike ibute mmepe nke nguzogide insulin.
Mmega ahụ. Ije ije n’ime ikuku dị mma, ịgba mwe mwe ọsọ, mmega ahụ na mgbatị ahụ, igwu mmiri na ụdị mmega ahụ ndị ọzọ ga-enyere aka ịba ụba kalori.
Nrube aka nke usoro onunu ogwu gi doziri. Ekwesịrị iji usoro a mee ihe na 3 mg kwa ụbọchị (ma e wezụga izu anọ mbụ, mgbe mmụba na-eji nwayọọ nwayọọ amalite).

Ihe kariri 80% ndị mmadụ na-ewere Liraglutide maka ịbelata oke nwere ezigbo omume. Achọpụtaghị 20% nke mgbanwe ndị ahụ.

Mkparịta ụka ọgwụ ọjọọ

N'oge usoro ọgwụgwọ, ịmịnye ozi na-egbu oge, nke na-emetụta ogo iwere ọgwụ ndị ọzọ. Ekwuputaghi nmekorita di otua, yabụ igbanwe ogwu ghari ime adighi nkpa.

Amachibidoro ngwakọta a na ọgwụ ndị ọzọ, maka nke a juputara na mbibi nke mpaghara arụ ọrụ ọgwụ ahụ.

Enwere ike iji Liraglutide eme ihe n'otu oge na thiazolidinedione na metformin dịka akụkụ nke usoro ọgwụgwọ dị mgbagwoju anya.

Ihe ngbanwe

Edebere ihe mgbochi iji ihe eji eme ihe na oke. Amachibidoro ịnye inje n'ihu nke ọnọdụ na ọrịa ndị a:

nnwere onwe onye ọzọ maka ihe ndị ọzọ dị mkpa,
ụdị shuga 1
nkụda obi (ụdị 3 na 4),
ọrịa kansa
oke mmebi nke akụrụngwa ma ọ bụ ọrụ ịba ọcha n'anya,
otutu endocrine neoplasia syndrome,
ọrịa mgbu,
oge ị breastụ ara, tụụrụ ime.

Ọkụ amụkwo ọrịa (nke amụrụ nchekwa nke ihe dị na ndị ọrịa a nyochabeghị),
agadi (ihe karịrị afọ 75),
na-abụrịrị maka insulin injection na ọgwụ ndị ọzọ nke GLP-1,
Ọrịa obi
ojiji nke mbadamba ihe ndị ọzọ na ihe ngwọta maka oke ibu.

A naghị akwado ya ịnye inje na nwata yana oge uto, n'ihi na mmeghachi ahụ nke anụ ahụ na - abanye na ngwa ahụ enweghị atụ. Naanị dọkịta nwere ike ịkọwa ọgwụ maka ndị ọrịa na-erubeghị afọ 18, na-agba mbọ hụ na enwere akara na enweghị mgbochi.

Nsonaazụ

Ọtụtụ mgbe, ndị ọrịa na-a liụ ọgwụ nke liraglutide nwere mmeghachi omume na-adịghị mma site na eriri afọ:

na 40% nke ikpe - ọgbụgbọ (mgbe ụfọdụ sonyere vomiting),
na 5% nke ikpe - nsogbu ọgbụgba (afọ ntachi, afọ ọsịsa).

Ekwesịrị ịkpachara anya na ndị nwere ọrịa shuga 2. N'ime mmadụ 3 n'ime ndị ọrịa 100, ọgwụgwọ ogologo oge na-eji liraglutide na-eduga na mmepe nke hypoglycemia.

Mmetụta ndị ọzọ na-apụta n'oge ọgwụgwọ gụnyere mmeghachi omume ndị a:

isi ọwụwa
ịba ụba gas,
ike ọgwụgwụ, ike ọgwụgwụ,
mmeghachi omume nfụkasị (gụnyere n'akụkụ ntụtụ)
ọrịa na-efe efe nke elu akụkụ iku ume,
mmụba obi - ọnụego obi.

A na-ahụkarị mmetụta ndị ọzọ na-adị n'ime ụbọchị 7-14 site na mmalite ọgwụgwọ. Ka oge na-aga, ahụ ga-eme ọgwụ ahụ, mmeghachi omume ndị na-adịghị mma na-eme ka ọ kpọọ aha gị. Ọ bụrụ na ihe ịtụnanya ndị a dị n'elu anaghị agafe onwe ha ma ọ bụ sie ike, ị kwesịrị ịkpọtụrụ dọkịta.

Ọgwụ ọgwụ ọjọọ

Pricegwọ nke liraglutide na ụlọ ahịa ọgwụ na-adabere na aha azụmaahịa na ọdịnaya nke ihe mejupụtara:

Victose, 6 mg / ml, 3 ml, 2 PC. - sitere na 9500 rub.,
Victoza, 18 mg / 3 ml, 2 PC. - site na 9000 rub.,
Saxenda, 6 mg / ml, 3 ml, 5 PC. - site na 27000 rub.

Ọ bụrụ na ojiji nke Saxend na Viktoz agaghị ekwe omume, ị ga-agakwuru dọkịta iji họrọ ọgwụ nwere mmetụta yiri ya. Otu n'ime usoro ọgwụgwọ ndị na-esonụ nwere ike ịghọ ụdị ọgwụ:

Novonorm (mbadamba). Edere ya maka ndị ọrịa nwere ọrịa shuga 2. Ejiri iji nwayọọ gwọọ glucose ọbara. Ọ bụ analogue kachasị akwụ ụgwọ (nkwakọ ngwaahịa na-eri 150-250 rubles).
Liksumiya (ihe ngwọta maka sc nchịkwa). Na-ebelata ọbara shuga n’agbanyeghi oge nri. Ọ na-efu 2500-7000 rubles.
Forsiga (mbadamba). Na-enyere aka iwelata glucose ma belata ọkwa shuga mgbe nri gachara. Ọnụ ego nke sirinji 1 bụ 1800-2800 rubles.
Byeta. Onye nnọchi anya amino acid amidopeptides. Na-eme ka ịkwa iko na-egbu mmụọ, na-egbochi agụụ, na-amalite usoro ifelata. Ọ bụ analog kasị dị oke ọnụ (sirinji 1 na-efu ihe dị ka 10,000 rubles.).

Naanị dọkịta nwere ike inye gị ụdị ọgwụ a. Nhọrọ nke nnwere onwe nke ndị na-ahụ maka hypoglycemic bụ nke enweghị usoro ọgwụgwọ na mmepe nke mmeghachi omume na-adịghị mma site na eriri afọ na usoro ahụ ndị ọzọ.

Inga, 45 afọ, Moscow: “Achọpụtara m ọrịa shuga afọ ise gara aga. Enwetụbeghị m ahụ dị mkpụmkpụ, mana n'afọ ndị na-adịbeghị anya, ịdị arọ nke anụ ahụ abụrụla ihe dị mkpa. Agbalịrị m ifelata site n’egwuregwu na ezigbo nri, mana ada ada. Dọkịta a zụrụ ọgwụ Saksenda n'ụdị edozi ma gosipụta otu esi eme inje ince n'ụzọ ziri ezi. Na mbụ ọ bụ egwu na enweghị ahụ iru ala, mana emesịa mụta ya. N'oge ọgwụgwọ, m jisiri ike kilogram 4, enwere m belata ugbu a. ”

Kirill, onye gbara afọ 51, St. Petersburg: “Apụghị m ifelata ruo mgbe m jekwuru onye na-ahụ maka nri. Ahụghị m ọgwụ mgbochi ọ bụla iji Liraglutide, yabụ dọkịta gwara m ka m nye ọgwụ mgbochi. Na ngwụcha nke ọmụmụ ahụ, ọ malitere iwere ọgwụ iji mee ka nsonaazụ ya guzosie ike. Ibu ibu ka na-alaghachi. "

Larisa, onye gbara afọ 42, Samara: “Agbalịrị m ọtụtụ nri maka oke belata, ma ọ dịghị nke nyere aka. Ekpebiri m ịmalite ị therapyụ ọgwụ ma gakwuru ọkà mmụta ọgwụ endocrinologist, onye depụtara ọgwụ ọgwụ Saksenda. N'ime ọnwa ole na ole enwere ike ida kilogram 5, mana usoro nke ifelata na-aga n'ihu ruo taa. Achọrọ m ịdọ ndị na-a thisụ ọgwụ a aka na ntị: ọ nweghị ihe nwere ike ịrụ ọrụ na-enweghị egwuregwu na ezigbo nri, yabụ gbalịa bie ụdị ndụ dị mma n'oge ọgwụgwọ na mgbe ọgwụgwọ gachara. ”

Ihe ngosiputa na idi nma nke ogwu

Ihe akpọrọ na ọgwụ dịka liraglutide bụ analogue nke anụmanụ jiri mkpụrụ ndụ eriri afọ mepụta - glucagon-like peptide-1 (GLP-1). N'ihi mmepe nke ndị ikpeazụ, a na -emepụta nsonaazụ saturation, nke na-ezere ịreatụbiga mmanya ókè na mmụba na-esote ibu. N'aka ozo, GLP-1 bu ihe omuma nke ihe omumu nke ihe oriri na nri.

A na-eji liraglutide na-enweghị atụ n'ụdị nkwadebe Saxenda na Victoza. Nolọ ọrụ ahụ Novo Nordisk (Denmark) na-arụ ọrụ na nrụpụta ha. Ogwu di iche-iche nke pen-syringe juputara na uzo a choro maka ochichi ala.

Omume na-egosi na iji ezigbo ọgwụ nke nwere liraglutide, ọ ga-ekwe omume nweta mbelata dị ukwuu n’arụ ahụ.

Edere ha ndị ọrịa na:

oria oria abuo, bu oke ibu, ya na aru ya.
BMI kariri iri ato n’enwe oria,
BMI nke 27, mgbe ọrịa ndị ọzọ na - arịa ọrịa na - eme n'oge uru oke (dịka ọmụmaatụ, ọbara mgbali elu ma ọ bụ cholesterol na - ebili),
nsogbu nke apnea, nke ejikọtara ya na ọdịdị nke paụnd ọzọ,
nsogbu glycemic index.

Clinical mmetụta na Njirimara

N'ịbụ nke a na-ahụ maka akwụkwọ glucagon dị ka mmadụ peptide-1 (97%), liraglutide na-enyere aka ịchịkwa mmepụta insulin, nke na-emesịa dozie glucose ọbara. Ihe ahụ nwere mmetụta na-adịte aka, nke, ọkachasị, bụ nsonaazụ nke oke nkwụsi ike nke enzymatic.

N'ihi liraglutide, ọtụtụ usoro dị mkpa na-apụta:

mkpụrụ ndụ beta nke a na-eme ka ọ bụrụ nke na-eme ka insulin na-akawanye mma
a na - egbochi mgbochi glucagon.

Ọ bụrụ na shuga dị ọbara bilitere, liraglutide na-akpali insulin na-egbochi ma gbochie imepụta glucagon. Site na hypoglycemia, uto nke analogue nke akwara nke GLP-1 bụ iji belata mwepụta nke insulin.

A na-ewepụ mkpokọta abụba mgbe a na-a liụ Liraglutide site na mbenata agụụ ma na-ebunye ya akara na ụbụrụ banyere ọdụ ngwa ngwa, ebe ahụ na-ahụ nri zuru oke na nri.

Nsonaazụ nke liraglutide n'ahụ

Liraglutide bụ gluptagon-dị ka peptide-1 (GLP-1) a rụkọrọ arụkọta arụ. Akwụkwọ ikike 97% kwekọrọ na homonụ sitere n'okike n'ụzọ.

Ime na ahu mgbe ochichi diri:

lowers shuga
na-akpali mmepụta nke peptides, glucagon na insulin,
na-eme ka nnabata nke nri jupụta,
ụbụrụ na - enweta akara ngwụsị ngwa ngwa.
a na-ebelata agụụ.

Site na ntinye nke liraglutide, mmeghachi omume ebuputa nke mmepụta insulin na-abụkarị nke ọma. A na-eweghachi ọrụ nke pancreas, ọnụego metabolic na-ebelata, agụụ na-ebelata.

Ihe ndị bụ isi contraindications

A maara onye na-ahụ maka hypoglycemic ọ bụghị naanị maka ike ya iji kpochapụ oke abụba. Enwere ọtụtụ contraindications kwesịrị ịtụle tupu ịmalite ọgwụgwọ.

A na-ewepụta ndepụta ha:

ụdị shuga 1
oké gbasara akụrụ na ọrịa ịba ọcha n'anya,
ụdị nkụpu nke ụdị 3-4,
ọrịa mgbu,
ọrịa mamịrị ketoacidosis,
paresis nke afo
akpụ akpụ akwara,
hypersensitivity na mmiri ọgwụ.

A machibidoro Liraglutide maka ojiji ruo afọ 18 na mgbe ọ gbasịrị 75, yana n'oge afọ ime yana n'oge a na-enye nwa ara.

Nsonaazụ

Ọtụtụ mgbe, inje nke ọgwụ ahụ na-akpata mmeghachi omume na-achọghị site na mgbaze nri. Ndị ọrịa na-ata ahụhụ site na ọgbụgbọ, ọgbụgbọ, stools iwe, nke na - ebute ọjụjụ iji Liraglutida.

A ga-agbakwunye ndepụta nke mmetụta ndị ọzọ:

ọrịa gallstone
ọria aru
tachycardia
ọrịa akụkụ akụkụ okuku ume na nke elu
isi ọwụwa
ike ọgwụgwụ,
mmeghachi omume nfụkasị.

Dabere na ndị dọkịta, mgbaàmà na-adịghị mma na-adị n'oge izu abụọ mbụ mgbe ebidochara usoro ọgwụgwọ, emesia ọ na-eji nwayọ na-apụ n'anya.

Ọdịmma nke liraglutide maka ịbelata ibu

Mmetụta nke ịbelata oke n'oge nnabata hụrụ 80% nke ndị ọrịa bụ ndị weere Victoza n'ọrịa mellitus. Mgbe ị na-eji liraglutide, a na-ebelata oke iri nri nri. Agụụ na-agụ agụụ, a na-eriju nri afọ na nke nri ị na-eri belata. A na-ewekarị ihe dị ka 20% obere.

Iji chọpụta etu Viktoza dịruru n'iyi n’ibelata oke, a nwalere nsonaazụ ọgwụ ahụ na omume. Nnwale ahụ metụtara ndị ọrụ afọ ofufo 564. E kee ndị ọrịa n’otu n’otu. Ha niile riri obere kalori ma zụọ ya kwa ụbọchị. Kama iji Victoza, a na-eji ọgwụ ikuku sụọkụ mbụ. E kenyere Xenical, ogwu nke nwere oke ibu bu ihe ndi bara n’iru n’enye ndi oru n’enyemaka n’ime ndi nke abuo. Ndị ọrịa nke otu nke atọ n'okpuru otu ọnọdụ ahụ gbara Viktoza injections.

Ha gosiputara na ihe ndi ozo gosipụtara site na ndi afọ ofufo nke otu nke ato. Ọnụ ọgụgụ nke ndị felata bu 75% ma e jiri ya tụnyere 30% na 45% nke ndị ọzọ fọdụrụnụ.

Na mgbakwunye, enwere ike igosipụta na maka ịdị na -ewelata ịdị arọ anụ ahụ kwụsịrị, usoro ọgwụ enyere maka iwu kwesịrị ịbụ opekata mpe 3 mg maka ihe ahụ na-arụ ọrụ.

Ha chọpụtakwara na iji felata, naanị ọgwụ ezughi oke. Usoro ndị dị mgbagwoju anya na-enyere aka belata ibu: nri kalori, mmega ahụ na ojiji nke Victoza.A na-atụ aro ya mgbe ị na-a theụ ọgwụ ahụ ịkwụsị ị smokingụ sịga na ị alcoholụ mmanya.

Mgbapụta ngwaahịa

Enweghị ọgwụ nri nwere Liraglutide, ọgwụ dị n'ụdị injections. N'ihe mgbagwoju anya maka oke ibu, a na-a medicineụ ọgwụ ahụ n’okpuru.

Ha na-azụta ọgwụ n'ime sirinji ndị nwere oge nke yiri sirinji insulin. Ọkpụkpụ nke ọ bụla nwere ọnụ ọgụgụ ya na nkewa dị iche iche, n'ihi nke ọgwụ a dosed. Ngwọta sitere na sirinji ezuru maka injections 10-30. Nwere ike itinye inje subcutaneous n'onwe gị, dịka ọ ka adaba: n'apata ụkwụ, afọ ma ọ bụ ubu.

Dị ka akụkụ nke ngwaahịa slimming:

liraglutide - ihe eji arụ ọrụ na-arụ ọrụ, n'ime 6 mg,
propylene glycol - 14 mg,
sodium hydrogen phosphate akpọnwụwo - 1.42 mg,
phenol - 5,5 mg
sodium hydroxide - ihe ruru 1 ml,
hydrochloric acid - 1 ml,
mmiri maka ịgba ntụtụ.

A na-enweta ọgwụ abụọ a na ọgwụ ọgwụ. Enwere ike ịzụta Victoza maka 9000-10000 rubles:

Ngwọta maka nchịkwa subcutaneous na ampoules, 6 mg / ml,
Mkpịsị sirinji na katriiki n'otu usoro onunu ogwu,
Mkpịsị mkpụrụ osisi na-enweghị kateeti - 18 mg / 3 ml.

Saxenda dịkarịa ala 27,000 rubles. Na ngwugwu nke sirinji 5 na ngwakọ nke 3 ml, nwekwara 6 mg / ml. Saxenda, nke a na-eresị na Russia, ka ụlọ ọrụ Denmark rụkwara ya.

Ọdịiche dị n'etiti Saksenda na Viktoza

Ejiri Saxenda nwere liraglutide maka oke ibu. Ebumnuche Victoza bụ mbido imebi ọkwa shuga.
Enwere ọgwụ ọzọ na Saxend pen-sirinji karịa sirinji ya na Viktoza.
Mgbe ị na-eji Saxenda maka ịdị felata, nsonaazụ ya anaghị apụtawanye obere oge.

Ntuziaka maka iji liraglutide

Mgbe ịzụtara, a na-etinye nkwakọ ngwaahịa ozugbo na friji, na shelf. Mgbe oyi kpọnwụrụ ma ọ bụ kpochaa ọkụ karịa + 25 Celsius C, a naghị echekwa ọgwụ ndị ahụ. Ogologo oge nchekwa 30 ọnwa site na ụbọchị mbipụta.

O kwere omume itinye ya n'ọrụ dịka akụkụ nke usoro ọgwụgwọ dị mgbagwoju anya yana ọgwụ ọzọ. Mgbe ị na-eji ya, mmetụta ndị na-eme mgbe ụfọdụ.

Ntuziaka maka iji ya na ọgwụ abụọ a nwere Liraglutide. O nwere ntuzi aka maka ochichi. Ọ bụrụ na enweghị ntuziaka pụrụ iche, a na-achịkwa ha dịka atụmatụ a dị, n'agbanyeghị ụdị ntọhapụ.

A na-eme atụmatụ ngụkọta nke ọgwụ a na-achịkwa dabere na ihe eji arụ ọrụ.

N'ime ụbọchị asaa site na mmalite nke ọgwụgwọ, 3 mg kwa ụbọchị. A na-agbakọ otu usoro dabere na ọnọdụ onye ọrịa. Oke kachasị nke mbụ bụ 1.8 mg.
Site na izu abụọ, usoro ịba ụba na-abawanye site na 0.6 mg ma gbakwunye ya kwa ụbọchị 7.
Ọdịda ahụ na-ada nwayọ, site na izu ise.
Ka ọ na-erule ngwụcha nke usoro ahụ, kwa ụbọchị kwa ụbọchị ọzọ bụ 3 mg.
Ọ bụrụ n ’irighi irighiri oge gị maka ihe ọ bụla, ị nwere ike tinye ọgwụ ọgwụ n’ime awa iri na abụọ. Site na igbu oge ihe kariri ọkara ụbọchị, agụrụ onye na-egbu oge.

Ọgwụ esiteghi na nri iri nri ma ọ bụ ọnọdụ ọrụ, mana ọ ga-adị mma ime ya n'otu oge. Otutu nke injections - ugboro 1-3 n'ụbọchị.

Maka ịdị mfe nke iji ya, a na-etinye ihe ize ndụ na sirinji ahụ, nke kwekọrọ na ọnụọgụ 0.6 mg - site na 0.6 ruo 3 mg, ya bụ, 0.6, 1.2, 2.4, wdg. Ekpebiwo oge ọ ga-eji gwọọ ya na usoro onunu ogwu ya, oge kacha nta bụ ọnwa 4, kachasi bụ ọnwa iri.

Ọ gaghị ekwe omume ifelata otu ọgwụ inraglutide ahụ. A na-ebelata ibu na usoro ihe mgbagwoju anya, gụnyere nri nwere obere kalori, mmega ahụ a na-ahụ anya ma were ọgwụ ndị ọzọ na-eme ka usoro metabolic dịkwuo elu. A na-ahọrọ ọgwụ ndị na-akwalite nsonye nke inje, na-eburu n'uchenesis.

Etu esi eji mkpịsị sirinji

Tupu ojiji mbụ:

Dị njikere ịlele ụbọchị ngafe.
Nyochaa onodu ogwu ahu. Ọ bụrụ na osisa ahụ dị urukpuru ma ọ bụ nwee oke izipu, a ga-atụfu nsị ahụ.
Wepu ihe nnyapade gị na mkpanaka nwere ike wepụ.
Fanye agịga ahụ na nro na syringe, wepu okpu mpụta, ma dobe ya ka enwee ike iji ya.
A na-atụfu okpu n'ime.
Pinye ngwa ngwa na mpekere nke sirinji ka ịpịpụta otu 1 mmiri. Ọ bụrụ na piston anaghị arụ ọrụ, ihe ngwọta adịghị apụta, a na-ewepụ sirinji ahụ.

Mgbe etinyere ya n’ahụ, emetụ akpụkpọ ahụ aka na mkpịsị aka iji gbochie ọrịa. A na-eji ọgwụ ahụ nwayọ nwayọ ka onye na - enye ọgwụ anaghị ebugharị nke ọma. Mgbe ọgwụ achọrọ gachara n’akpụkpọ ahụ, a dịghị ewepụta agịga ozugbo ka ọgwụ ahụ wee ghara ịpụ. A na-atụ aro ka ọnụọgụ 6 ruo naanị wepu agịga. A na-agbanye owu na-amị amị amịkụl.

Tupu iwepu sirinji ya na iji gwọo ọnya ndị ga-esochi ya, a na-etinye agịga ejirila na okpu nchebe. A na-etinye ikpe na sirinji, nke na-echebe ngwọta site na ìhè.

Analogs nke liraglutide maka oke ibu

Analogs nke ọgwụ mbụ dị na ọrụ:

Novonorm, mbadamba nkume, ruble 160. Ihe omume a yiri ya, mana iji ya adịghị mma. Ogologo oge nchịkwa ugboro anọ kwa ụbọchị na ọnụọgụ ọ bụla n'otu oge. Ọgwụ kwa ụbọchị bụ mg 16, a na-ebu mbadamba tupu nri.
Diaglinid, 200 rubles. Ceptionnabata ga-amalite site na iji ọgwụ 0,5 mg, emesịa jiri nwayọ bulie ma weta 12 mg na nha atọ.
Orsoten, 600 rubles. Nkwanye maka iji - nkeji iri atọ tupu nri ma ọ bụ nkeji iri anọ na ise mgbe ọnwa 45-60 gachara. A na enweta ya na capsules indivisible, ego nke ihe na-arụ ọrụ n'ime mkpụrụ ọgwụ iri na abụọ ọ bụla. Na-a onceụ otu ugboro n'ụbọchị.
Reduxin, usoro ọgwụgwọ kachasị ewu ewu, 1600 rubles. Ogologo oge a na-eme ọgwụgwọ sitere na ọnwa 3 ruo afọ abụọ, kwa ụbọchị nke 10 mg, hapụ - capsules.
Forsyga, ọnụahịa nke 2400 rubles. Ndụmọdụ maka iji ya bụ ihe a na-eme ka ya nwee ebelata ya.
Baeta na pen sirinji. Ejiri iji belata agụụ, belata ọnụego nke peristalsis. Ihe ruru puku 10,000 rubles.
Liksumia - 2500-7000 rubles. Lowers shuga ọbara, n'agbanyeghị nri.

Tupu ịhọrọ analog, ọ ga-adị mma ka ị kpọtụrụ dọkịta gị. Ihe ndi eji egbochi ogwu ime ya na ihe omuma ya n’ahu usoro onunu ogwu di iche. Iji amaghi ihe na-emetụta ahụ ike.

Kedu analog nke liraglutide ka mma?

Ọtụtụ ndị ọrịa enweghị ike ịkwụ ọgwụ maka ụgwọ ya dị oke elu. Ihe di nkpa di nkpa. Kama ịgbanye liraglutide, ịnwere ike iji mbadamba ego dị ọnụ ala karịa nke ụdị dị iche iche. Isi ihe bụ na ọkachamara ga-ahọpụta ọgwụgwọ maka oke ibu.

Ihe analogue obula nwekwara contraindications, ya mere, odi nma ka iwepu itinye aka na ego eji aka ya.

Nyocha banyere ifelata gbasara ọgwụ

Ndị ọrịa na-arịa oke ibu na-ekwu ihe dị iche iche banyere Lyraglutide. N’aka nke aka, ogwu nwere ike inye aka n’emegide njuputa, ebe o n’eme ihe di nma na ogo shuga.

Mana n’otu oge, ọgwụ a na - ebutekarị ọria mgbawa n’ụdị ọgbụgbọ na ọgbụgbọ, nke na - esikarị ike ịnagide ya. Na mgbakwunye, ndị ọrịa na-ekwu na ọnụ ahịa dị elu maka ọghọm nke onye na - ahụ maka hypoglycemic, nke bụ otu n'ime isi ihe mere eji ajụ injections.

Na-enweghị contraindications, dọkịta nwere ike inye ndụmọdụ maka ọgwụgwọ Lyraglutide, nke ọ ga-ekwe omume belata oke ahụ gị ma mezie ọkwa glucose. Iji nweta nsonaazụ achọrọ, ọ dị mkpa iji ọgwụ ahụ n'ụzọ ziri ezi, na-agbakwunye ọgwụ nri na mmega ahụ na-adịghị mma.